HCTI — Healthcare Triangle Income Statement
0.000.00%
Last trade - 00:00
- $3.21m
- $5.59m
- $33.20m
- 18
- 58
- 16
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28.7 | 31.3 | 35.3 | 45.9 | 33.2 |
Cost of Revenue | |||||
Gross Profit | 5.85 | 8.59 | 10.5 | 11.3 | 6.78 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 27.1 | 30.2 | 40.6 | 56.3 | 44.6 |
Operating Profit | 1.67 | 1.18 | -5.36 | -10.4 | -11.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.62 | 2.61 | -5.93 | -9.55 | -12.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.17 | 2.35 | -5.95 | -9.61 | -12.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.17 | 2.35 | -5.95 | -9.61 | -12.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.17 | 2.35 | -5.95 | -9.61 | -12.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.301 | 0.604 | -2.02 | -2.62 | -2.16 |
Dividends per Share |